• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度表型分析在帕金森病精准医学中的应用。

Deep phenotyping for precision medicine in Parkinson's disease.

机构信息

UK Dementia Research Institute at Cardiff University, Division of Psychological Medicine and Clinical Neuroscience, Haydn Ellis Building, Maindy Road, Cardiff CF24 4HQ, UK.

出版信息

Dis Model Mech. 2022 Jun 1;15(6). doi: 10.1242/dmm.049376.

DOI:10.1242/dmm.049376
PMID:35647913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9178512/
Abstract

A major challenge in medical genomics is to understand why individuals with the same disorder have different clinical symptoms and why those who carry the same mutation may be affected by different disorders. In every complex disorder, identifying the contribution of different genetic and non-genetic risk factors is a key obstacle to understanding disease mechanisms. Genetic studies rely on precise phenotypes and are unable to uncover the genetic contributions to a disorder when phenotypes are imprecise. To address this challenge, deeply phenotyped cohorts have been developed for which detailed, fine-grained data have been collected. These cohorts help us to investigate the underlying biological pathways and risk factors to identify treatment targets, and thus to advance precision medicine. The neurodegenerative disorder Parkinson's disease has a diverse phenotypical presentation and modest heritability, and its underlying disease mechanisms are still being debated. As such, considerable efforts have been made to develop deeply phenotyped cohorts for this disorder. Here, we focus on Parkinson's disease and explore how deep phenotyping can help address the challenges raised by genetic and phenotypic heterogeneity. We also discuss recent methods for data collection and computation, as well as methodological challenges that have to be overcome.

摘要

医学基因组学的一个主要挑战是理解为什么具有相同疾病的个体具有不同的临床症状,以及为什么具有相同突变的个体可能受到不同疾病的影响。在每种复杂疾病中,确定不同遗传和非遗传风险因素的贡献是理解疾病机制的关键障碍。遗传研究依赖于精确的表型,并且当表型不精确时,无法发现疾病的遗传贡献。为了解决这一挑战,已经开发出了深度表型队列,这些队列收集了详细的、精细的数据集。这些队列帮助我们研究潜在的生物学途径和风险因素,以确定治疗靶点,从而推进精准医学。神经退行性疾病帕金森病的表型表现多样,遗传度适中,其潜在的疾病机制仍存在争议。因此,为这种疾病开发了深度表型队列。在这里,我们专注于帕金森病,并探讨深度表型如何帮助解决遗传和表型异质性带来的挑战。我们还讨论了最近的数据收集和计算方法,以及必须克服的方法学挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/d249ae306d07/dmm-15-049376-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/71443f086625/dmm-15-049376-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/9bf4b60a3771/dmm-15-049376-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/272e658d275f/dmm-15-049376-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/04d3f4138403/dmm-15-049376-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/fc0921c4b2a1/dmm-15-049376-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/d523ae91923a/dmm-15-049376-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/d249ae306d07/dmm-15-049376-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/71443f086625/dmm-15-049376-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/9bf4b60a3771/dmm-15-049376-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/272e658d275f/dmm-15-049376-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/04d3f4138403/dmm-15-049376-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/fc0921c4b2a1/dmm-15-049376-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/d523ae91923a/dmm-15-049376-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/9178512/d249ae306d07/dmm-15-049376-g7.jpg

相似文献

1
Deep phenotyping for precision medicine in Parkinson's disease.深度表型分析在帕金森病精准医学中的应用。
Dis Model Mech. 2022 Jun 1;15(6). doi: 10.1242/dmm.049376.
2
Universal clinical Parkinson's disease axes identify a major influence of neuroinflammation.通用临床帕金森病轴确定了神经炎症的主要影响。
Genome Med. 2022 Nov 16;14(1):129. doi: 10.1186/s13073-022-01132-9.
3
Modeling Parkinson's Disease Heterogeneity to Accelerate Precision Medicine.建立帕金森病异质性模型以加速精准医学发展。
Trends Mol Med. 2019 Dec;25(12):1052-1055. doi: 10.1016/j.molmed.2019.09.004. Epub 2019 Oct 30.
4
Emerging Role of Precision Medicine in Cardiovascular Disease.精准医学在心血管疾病中的新兴作用。
Circ Res. 2018 Apr 27;122(9):1302-1315. doi: 10.1161/CIRCRESAHA.117.310782.
5
[Emerging concepts for precision medicine in Parkinson's disease with focus on genetics].[帕金森病精准医学的新兴概念,重点关注遗传学]
Fortschr Neurol Psychiatr. 2020 Sep;88(9):558-566. doi: 10.1055/a-1149-2204. Epub 2020 Jun 2.
6
Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.组学数据及其整合分析支持神经退行性疾病的分层医学
Int J Mol Sci. 2021 May 1;22(9):4820. doi: 10.3390/ijms22094820.
7
Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.帕金森病的遗传学:对精准医学之旅的反思。
Neurobiol Dis. 2020 Apr;137:104782. doi: 10.1016/j.nbd.2020.104782. Epub 2020 Jan 25.
8
Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal.LRRK2 和 GBA 风险变异帕金森病患者的精准医学——让我们变得更加个体化。
Transl Neurodegener. 2020 Oct 16;9(1):39. doi: 10.1186/s40035-020-00218-x.
9
Uses for humanised mouse models in precision medicine for neurodegenerative disease.用于神经退行性疾病精准医学的人源化小鼠模型的用途。
Mamm Genome. 2019 Aug;30(7-8):173-191. doi: 10.1007/s00335-019-09807-2. Epub 2019 Jun 15.
10
The genetic architecture of Parkinson's disease.帕金森病的遗传结构。
Lancet Neurol. 2020 Feb;19(2):170-178. doi: 10.1016/S1474-4422(19)30287-X. Epub 2019 Sep 11.

引用本文的文献

1
Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson's Disease.帕金森病早期有意义症状及功能影响的系统评价与共识概念模型
NPJ Parkinsons Dis. 2025 Apr 3;11(1):65. doi: 10.1038/s41531-025-00907-2.
2
From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care.从意外发现到精准医疗:整合人工智能、多组学和人类特异性模型以实现个性化神经精神疾病护理。
Biomedicines. 2025 Jan 12;13(1):167. doi: 10.3390/biomedicines13010167.
3
Emerging perspectives on precision therapy for Parkinson's disease: multidimensional evidence leading to a new breakthrough in personalized medicine.

本文引用的文献

1
Reproducibility in the UK biobank of genome-wide significant signals discovered in earlier genome-wide association studies.英国生物银行重现了先前全基因组关联研究中发现的全基因组显著信号。
Sci Rep. 2021 Sep 20;11(1):18625. doi: 10.1038/s41598-021-97896-y.
2
Comprehensive subtyping of Parkinson's disease patients with similarity fusion: a case study with BioFIND data.基于相似性融合的帕金森病患者综合亚型分析:一项使用BioFIND数据的案例研究
NPJ Parkinsons Dis. 2021 Sep 17;7(1):83. doi: 10.1038/s41531-021-00228-0.
3
Cognitive deficits in people who have recovered from COVID-19.
帕金森病精准治疗的新视角:通向个性化医疗新突破的多维度证据
Front Aging Neurosci. 2024 Jul 4;16:1417515. doi: 10.3389/fnagi.2024.1417515. eCollection 2024.
4
Fox Insight at 5 years - a cohort of 54,000 participants contributing longitudinal patient-reported outcome, genetic, and microbiome data relating to Parkinson's disease.Fox Insight 研究 5 年结果:54000 名参与者的队列研究,提供与帕金森病相关的纵向患者报告结局、遗传和微生物组数据。
Sci Data. 2024 Jun 12;11(1):615. doi: 10.1038/s41597-024-03407-9.
5
Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics.探索机器学习在神经退行性疾病治疗中的前沿领域。
Pharmaceuticals (Basel). 2024 Jan 25;17(2):158. doi: 10.3390/ph17020158.
6
Precision medicine for Parkinson's disease: The subtyping challenge.帕金森病的精准医学:亚型分类挑战。
Front Aging Neurosci. 2022 Dec 1;14:1064057. doi: 10.3389/fnagi.2022.1064057. eCollection 2022.
7
Genetic variance in human disease - modelling the future of genomic medicine.人类疾病的遗传变异 - 基因组医学的未来建模。
Dis Model Mech. 2022 Jun 1;15(6). doi: 10.1242/dmm.049700. Epub 2022 Jun 30.
新冠康复者的认知缺陷。
EClinicalMedicine. 2021 Sep;39:101044. doi: 10.1016/j.eclinm.2021.101044. Epub 2021 Jul 23.
4
Behavioral Phenotyping in a Murine Model of -Associated Parkinson Disease.- 相关帕金森病的小鼠模型中的行为表型。
Int J Mol Sci. 2021 Jun 25;22(13):6826. doi: 10.3390/ijms22136826.
5
The inconsistency and instability of Parkinson's disease motor subtypes.帕金森病运动亚型的不一致性和不稳定性。
Parkinsonism Relat Disord. 2021 Jul;88:13-18. doi: 10.1016/j.parkreldis.2021.05.016. Epub 2021 May 21.
6
Swarm Learning for decentralized and confidential clinical machine learning.群体学习用于去中心化和保密的临床机器学习。
Nature. 2021 Jun;594(7862):265-270. doi: 10.1038/s41586-021-03583-3. Epub 2021 May 26.
7
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature.用于帕金森病诊断的机器学习:文献综述
Front Aging Neurosci. 2021 May 6;13:633752. doi: 10.3389/fnagi.2021.633752. eCollection 2021.
8
Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource.加速药物研发合作组织:帕金森病。遗传资源。
Mov Disord. 2021 Aug;36(8):1795-1804. doi: 10.1002/mds.28549. Epub 2021 May 7.
9
Four distinct trajectories of tau deposition identified in Alzheimer's disease.阿尔茨海默病中tau 沉积的四种不同轨迹。
Nat Med. 2021 May;27(5):871-881. doi: 10.1038/s41591-021-01309-6. Epub 2021 Apr 29.
10
Phenotype discovery from population brain imaging.从群体大脑影像中发现表型
Med Image Anal. 2021 Jul;71:102050. doi: 10.1016/j.media.2021.102050. Epub 2021 Mar 31.